Anhui New Star Pharmaceutical Development

Anhui New Star Pharmaceutical Development is a comprehensive pharmaceutical enterprise based in Hefei, China, specializing in the research, development, and manufacturing of high-end generic drugs and innovative small molecules. Founded in 2003, the company has built a diverse portfolio focusing on therapeutic areas such as cardiovascular health, infectious diseases, and gastroenterology. It operates integrated R&D centers and GMP-compliant manufacturing facilities, providing contract development and manufacturing (CDMO) services to global partners. The company is recognized for its expertise in complex chemical synthesis and the production of high-quality active pharmaceutical ingredients (APIs). Anhui New Star Pharmaceutical continues to expand its international footprint by supplying essential medicines and intermediates to markets worldwide.